Beyond the numbers: Rational and ethical application of outcome models for organ allocation in liver transplantation

Liver Transplantation

Volumn 13, Issue 8, 2007, Pages 1080-1083

  Biggins, Scott W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

AGE; BENEFICENCE; CLINICAL PRACTICE; DEATH; DISEASE ASSOCIATION; EDITORIAL; EVIDENCE BASED MEDICINE; GRAFT SURVIVAL; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; HYPONATREMIA; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK ASSESSMENT; UNITED STATES;

ETHICS, MEDICAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT;

EID: 34548182792     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21210     Document Type: Editorial

References (43)

1. Biggins SW, Feng S. In a MELD-based economy, how can we fight off inflation? Liver Transpl 2007;13:2-4.
2. Biggins SW, Bambha K. MELD-based liver allocation: who is underserved? Semin Liver Dis 2006;26:211-220.
3. Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations. Liver Transpl 2002;8:313-322.
4. Ubel PA, Baron J, Asch DA. Social responsibility, personal responsibility, and prognosis in public judgments about transplant allocation. Bioethics 1999;13:57-68.
5. Libel PA, Arnold RM, Caplan AL. Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA 1993;270:2469-2474.
6. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313.
7. Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
8. Wiesner RH. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol 2005;2:24-30.
9. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
10. UNOS. Organ distribution: allocation of livers policy. Available at: http://www.unos.org. Last accessed 12 June 2007.
11. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
12. Amin MG, Wolf MP, TenBrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, Wong JB. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004;10: 1468-1475.
13. Biggins SW. How effective are 3-month and 12-month predictive models of mortality after first liver transplantation? Nat Clin Pract Gastroenterol Hepatol 2006;3:430-431.
14. Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007;13: 1174-1180.
15. Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl 2007;13:1115-1124.
16. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al, Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810.
17. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652-1660.
18. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005;41: 32-39.
19. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11:336-343.
20. Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 2006;44:1535-1542.
21. Biggins SW, Colquhoun S, Gish RG, Runyon BA. Model for end-stage liver disease (MELD) exception for ascites. Liver Transpl 2006;12(Suppl 3):S88-S90.
22. Abbasoglu O, Goldstein RM, Vodapally MS, Jennings LW, Levy MF, Husberg BS, Klintmalm GB. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998;12:263-269.
23. Londono MC, Guevara M, Rimola A, Navasa M, Taura P, Mas A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006;130:1135-1143.
24. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients - incidence, timing, and longterm follow-up. Clin Transplant 2000;14:1-7.
25. Wijdicks EF, Blue PR, Steers JL, Wiesner RH. Central pontine myelinolysis with stupor alone after orthotopic liver transplantation. Liver Transpl Surg 1996;2:14-16.
26. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
27. Ripoll C, Banares R, Rincon D, Catalina MV, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology 2005;42:793-801.
28. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7.
29. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430-436.
30. Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 2006;21:1519-1524.
31. Earley L, Sanders C. The effect of changing serum osmolality on the release of antidiuretic hormone in certain patients with decompensated cirrhosis of the liver and low osmolality. J Clin Invest 1959;38:545-550.
32. Cosby RL, Yee B, Schrier RW. New classification with prognostic value in cirrhotic patients. Miner Electrolyte Metab 1989;15:261-266.
33. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-236.
34. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003;38(Suppl 1):S69-S89.
35. Shear L, Kleinerman J, Gabuzda GJ. Renal failure in patients with cirrhosis of the liver. Clinical and pathologic characteristics. Am J Med 1965;39:184-198.
36. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46-52.
37. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482-487.
38. Biggins S, Kremers W, Benson J, Therneau T, Kim W. Impact of hyponatremia on mortality among liver transplant candidates in the US. Hepatology 2006;44:233A.
39. Schaubel DE, Sima C, Goodrich NP, Feng S, Merion R. Survival benefit of liver transplantation by MELD and Donor Risk Index. Transplantation 2006;82(Suppl 3):95A.
40. Benson J, Kim WR, Biggins SW, Therueau T, Kremer W, Gores G, et al. Outcome of liver transplantation in patients with hyponatremia. Hepatology 2005;42:328A.
41. Freeman RB. MELD: the holy grail of organ allocation? J Hepatol 2005;42:16-20.
42. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002;359:287-293.
43. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006;12:1594-1606.